If ongoing news reports of pharmacy product contaminations, recalls and patient injuries aren't enough to prompt reforms to reduce errors in the compounding of IV medications, a study published late last year — which shows the significant cost burden hospitals bear from IV medication errors — should be.
The report, in the journal American Health & Drug Benefits, found that preventable adverse drug events from IV drugs harm more than 1 million patients annually in U.S. hospitals, costing between $2.7 billion and $5.1 billion each year — an average of $600,000 per hospital.
continue to read here
No comments:
Post a Comment